Fabian Koenigbauer practices all aspects of patent law, domestically and internationally. He helps clients protect, patent and commercialize inventions, predominantly in the life sciences. He also helps clients assert their intellectual property rights and defend against infringement allegations.
For his clients, he manages global patent portfolios, prepares, files and prosecutes domestic and foreign patent applications. He also prepares validity, infringement, freedom-to-operate and patentability opinions. Mr. Koenigbauer participates in intellectual property transactions, such as due diligences, and in strategic intellectual property counseling including portfolio development, licensing and litigation. In addition to conducting legal and technical research, he also assists with patent litigations.
Mr. Koenigbauer advises clients ranging from small companies to Fortune 500 companies to universities and start-ups in a variety of technologies, such as vaccines, biologics, stem cell technology, chemical mechanical polishing, molecular biology/biotechnology (genomics, proteomics and synthetic devices), medical devices (catheters), microsensors, chemicals and compounds.
Significant Matters
Strategic management and development of global patent portfolios directed to biologics in pre-clinical and clinical studies.
Represented organ and tissue transplant provider in patent infringement suit involving bone graft cleaning and bone demineralizing technologies that resulted in a $23 million jury verdict in client's favor.
Represented provider of electronic polishing products in patent declaratory judgment action.
Represented water treatment device manufacturer in multiple domestic and foreign patent enforcement proceedings.
Industries
Life Sciences
Memberships
Bar Association of the District of Columbia
Intellectual Property Owners Association
News
February 14, 2012, BIO and PhRMA file amicus brief for Marine Polymer Technologies Federal Circuit en banc review on patent reexamination
January 27, 2012, Publications continue to highlight new patent group members
January 24, 2012, Publications feature new patent group members move to Venable
January 23, 2012, Venable Strengthens National Patent Prosecution/Litigation Practice with Addition of Five-Attorney Group, Including Three Partners
Publications
May 2012, Venable Vitae - May 2012
Fabian M. Koenigbauer, Bruce R. Parker, Ralph S. Tyler, Therese M. Finan, Michael A. Gollin, Meaghan Hemmings Kent
March 2012, IP Buzz - March 2012
Meaghan Hemmings Kent, Clifton E. McCann, Elissa Brockbank Reese, Jeffrey D. Knowles, Christopher S. Crook, Meaghan Hemmings Kent, Lars H. Genieser, Ph.D., Michael A. Gollin, Fabian M. Koenigbauer, Meaghan Hemmings Kent
IP Buzz
March 29, 2012, Federal Circuit Clarifies the Scope of Intervening Rights
Michael A. Gollin, Meaghan Hemmings Kent, Fabian M. Koenigbauer
2003, EZ-Rules™ for Patent Law
Fabian M. Koenigbauer, Elizabeth Hochberg
Law Rev. Publg. Corp.
2003, EZ-Rules™ for Intellectual Property Law
Fabian M. Koenigbauer, Elizabeth Hochberg
Law Rev. Publg. Corp.